Scand.J Clin Lab Invest 1985;45(2):169-178
Overall, the GLP-1 RAs therapy in patients with SIH and SID was not associated with increased episodes of hypoglycaemia
Those trials suggest that, while perhaps not quite as impressive as its injectable peptide cousins, the drug is still safe and effective at inducing significant weight loss
What they do know is that many conditions are associated with dysregulations or deficiencies in glutathione, such as: Neurodegenerative diseases like Parkinsons disease and Alzheimers disease Age-related cataracts, macular degeneration, and glaucoma as well as age-related hearing impairments Cancer Cardiovascular disease - especially hypertension and atherosclerosis
Crajoinas RO, Polidoro JZ, Carneiro de Morais CP, Castelo-Branco RC, Girardi AC
But many